复星医药2025年一季报:创新成果持续兑现,加速股份回购提振信心

复星医药
Apr 29, 2025

(2025年4月29日,中国上海)4月29日,复星医药(600196.SH;02196.HK)公布2025年第一季度业绩报告。2025年一季度,复星医药实现营业收入人民币94.20亿元,归母净利润人民币7.65亿元,经营活动现金流人民币10.56亿元。与此同时,复星医药持续推进非战略非核心资产的退出和整合,持续推进资产结构优化,加速现金回流。01多项创新成果持续兑现惠及全球患者2025年以来,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10